Page last updated: 2024-10-21

1,5-dihydroxyisoquinoline and Diabetic Glomerulosclerosis

1,5-dihydroxyisoquinoline has been researched along with Diabetic Glomerulosclerosis in 1 studies

1,5-dihydroxyisoquinoline: structure in first source
isoquinoline-1,5-diol : An isoquinolinol that is isoquinoline in which the hydrogens at positions 1 and 5 are replaced by hydroxy groups.

Research Excerpts

ExcerptRelevanceReference
"Variables of diabetic nephropathy in urine and renal cortex were evaluated by ELISA, Western blot analysis, immunohistochemistry, and colorimetry."1.35Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy. ( Drel, VR; Obrosova, IG; Pavlov, IA; Shevalye, H; Slusher, B; Xu, W; Zhang, J, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drel, VR1
Xu, W1
Zhang, J1
Pavlov, IA1
Shevalye, H1
Slusher, B1
Obrosova, IG1

Other Studies

1 other study available for 1,5-dihydroxyisoquinoline and Diabetic Glomerulosclerosis

ArticleYear
Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
    Endocrinology, 2009, Volume: 150, Issue:12

    Topics: Albuminuria; Animals; Blood Glucose; Blotting, Western; Body Weight; Creatinine; Diabetes Mellitus,

2009